Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Second Quarter of Fiscal 2025 on Wednesday, May 7, 2025, prior to the opening of trading on the New York Stock ...

Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Cencora COR +0.57% Get Free Report has outperformed the market over the past 10 years by 7.55% on an annualized basis ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

According to a Bloomberg report, the French-based Walden Group, a company specializing in pharmaceutical logistics, is ...

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers ...

AbbVie, Danaher, Thermo Fisher Scientific, Cognizant Technology Solutions, Vertex Pharmaceuticals, Alnylam Pharmaceuticals, ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

“Alto helps our partners elevate the patient experience, improve medication access and set new standards for convenience, ...

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including Cencora (NYSE:COR) and its peers. Upfront ...